(2) Trevogrumab is an antibody that targets myostatin in its pro-, latent, and mature forms, and is being administered together with garetosmab, an antiactivin A antibody, and semaglutide in the ongoing obesity trial NCT06299098
However, panic attacks typically involve a constellation of symptoms with prominent psychological features (intense fear, sense of impending doom) that are not characteristic of medication side effects alone
These investigations may also facilitate the identification of markers indicative of beneficial responses, providing valuable insights for informing the development of biostimulant products
2 GLP-1RAs taken once weekly may take four to five weeks to achieve steady state, while clinical effectiveness may be longer depending on many factors such as age, sex, body weight, and liver and kidney function